Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.
The medical device maker saw increased revenue, but earnings lagged estimates.
NVRO earnings call for the period ending September 30, 2021.
NVRO earnings call for the period ending June 30, 2021.
NVRO earnings call for the period ending March 31, 2021.
NVRO earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
